{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:22:39Z","timestamp":1791202959273,"version":"4.2.0"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["16\/RC\/3948"],"award-info":[{"award-number":["16\/RC\/3948"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    There remains a need for new drug targets for treatment-resistant temporal lobe epilepsy. The ATP-gated P2X7 receptor coordinates neuroinflammatory responses to tissue injury. Previous studies in mice reported that the P2X7 receptor antagonist JNJ-47965567 suppressed spontaneous seizures in the intraamygdala kainic acid model of epilepsy and reduced attendant gliosis in the hippocampus. The drug-resistance profile of this model is not fully characterised, however, and newer P2X7 receptor antagonists with superior pharmacokinetic profiles have recently entered clinical trials. Using telemetry-based continuous EEG recordings in mice, we demonstrate that spontaneous recurrent seizures in the intraamygdala kainic acid model are refractory to the common anti-seizure medicine levetiracetam. In contrast, once-daily dosing of JNJ-54175446 (30\u00a0mg\/kg, intraperitoneal) resulted in a significant reduction in spontaneous recurrent seizures which lasted several days after the end of drug administration. Using a combination of immunohistochemistry and\n                    <jats:italic>ex vivo<\/jats:italic>\n                    radiotracer assay, we find that JNJ-54175446-treated mice at the end of recordings display a reduction in astrogliosis and altered microglia process morphology within the ipsilateral CA3 subfield of the hippocampus, but no difference in P2X7 receptor surface expression. The present study extends the characterisation of the drug-resistance profile of the intraamygdala kainic acid model in mice and provides further evidence that targeting the P2X7 receptor may have therapeutic applications in the treatment of temporal lobe epilepsy.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2023.1308478","type":"journal-article","created":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:13:45Z","timestamp":1704672825000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":19,"title":["Anti-seizure effects of JNJ-54175446 in the intra-amygdala kainic acid model of drug-resistant temporal lobe epilepsy in mice"],"prefix":"10.3389","volume":"14","author":[{"given":"Omar","family":"Mamad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Heiland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas U.","family":"Lindner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D. M.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan M.","family":"Ronroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kilian","family":"Rentrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaya","family":"Sanz-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Langa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janosch P.","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Llop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anindya","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ceusters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Henshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nri1664","article-title":"Interleukin-1 and neuronal injury","volume":"5","author":"Allan","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neuropharm.2016.01.018","article-title":"P2X7 receptor antagonism reduces the severity of spontaneous seizures in a chronic model of temporal lobe epilepsy","volume":"105","author":"Amhaoul","year":"2016","journal-title":"Neuropharmacology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.tins.2006.03.003","article-title":"Emerging challenges of assigning P2X7 receptor function and immunoreactivity in neurons","volume":"29","author":"Anderson","year":"2006","journal-title":"Trends Neurosci."},{"key":"B4","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1523\/JNEUROSCI.22-14-05938.2002","article-title":"Activation of presynaptic P2X7-like receptors depresses mossy fiber-CA3 synaptic transmission through p38 mitogen-activated protein kinase","volume":"22","author":"Armstrong","year":"2002","journal-title":"J. Neurosci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/epi.13783","article-title":"Neuroinflammatory targets and treatments for epilepsy validated in experimental models","volume":"58","author":"Aronica","year":"2017","journal-title":"Epilepsia"},{"key":"B6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fnins.2017.00021","article-title":"The ATP-gated P2X7 receptor as a target for the treatment of drug-resistant epilepsy","volume":"11","author":"Beamer","year":"2017","journal-title":"Front. Neurosci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1111\/bph.15785","article-title":"Increased expression of the ATP-gated P2X7 receptor reduces responsiveness to anti-convulsants during status epilepticus in mice","volume":"179","author":"Beamer","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"105048","DOI":"10.1016\/j.nbd.2020.105048","article-title":"Genome-wide microRNA profiling of plasma from three different animal models identifies biomarkers of temporal lobe epilepsy","volume":"144","author":"Brennan","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1111\/epi.16714","article-title":"High concordance between hippocampal transcriptome of the mouse intra-amygdala kainic acid model and human temporal lobe epilepsy","volume":"61","author":"Conte","year":"2020","journal-title":"Epilepsia"},{"key":"B10","doi-asserted-by":"publisher","first-page":"18024","DOI":"10.1038\/nrdp.2018.24","article-title":"Epilepsy","volume":"4","author":"Devinsky","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1111\/epi.16956","article-title":"Microglia proliferation plays distinct roles in acquired epilepsy depending on disease stages","volume":"62","author":"Di Nunzio","year":"2021","journal-title":"Epilepsia"},{"key":"B12","doi-asserted-by":"publisher","first-page":"105689","DOI":"10.1016\/j.nbd.2022.105689","article-title":"P2X7-dependent constitutive Interleukin-1\u03b2 release from pyramidal neurons of the normal mouse hippocampus: evidence for a role in maintenance of the innate seizure threshold","volume":"168","author":"Dutta","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1096\/fj.11-196089","article-title":"Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice","volume":"26","author":"Engel","year":"2012","journal-title":"FASEB J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0156468","DOI":"10.1371\/journal.pone.0156468","article-title":"Critical evaluation of P2X7 receptor antagonists in selected seizure models","volume":"11","author":"Fischer","year":"2016","journal-title":"PloS One"},{"key":"B15","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/B978-0-12-804066-9.00042-0","article-title":"Poststatus epilepticus models: focal kainic acid","volume-title":"Models of seizures and epilepsy","author":"Henshall","year":"2017"},{"key":"B16","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1146\/annurev-pathol-052016-100138","article-title":"Focal cortical dysplasia: gene mutations, cell signaling, and therapeutic implications","volume":"12","author":"Iffland","year":"2017","journal-title":"Annu. Rev. Pathol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"5920","DOI":"10.1523\/JNEUROSCI.4009-15.2016","article-title":"Transient P2X7 receptor antagonism produces lasting reductions in spontaneous seizures and gliosis in experimental temporal lobe epilepsy","volume":"36","author":"Jimenez-Pacheco","year":"2016","journal-title":"J. Neurosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e36217","DOI":"10.7554\/eLife.36217","article-title":"Re-evaluation of neuronal P2X7 expression using novel mouse models and a P2X7-specific nanobody","volume":"7","author":"Kaczmarek-Hajek","year":"2018","journal-title":"Elife"},{"key":"B19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.neuropharm.2014.11.008","article-title":"Inter-individual variation in the effect of antiepileptic drugs in the intrahippocampal kainate model of mesial temporal lobe epilepsy in mice","volume":"90","author":"Klein","year":"2015","journal-title":"Neuropharmacology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/s0014-2999(98)00410-5","article-title":"Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy","volume":"353","author":"Klitgaard","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1056\/NEJMra1004418","article-title":"Drug-resistant epilepsy","volume":"365","author":"Kwan","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1002\/acn3.51229","article-title":"Anakinra usage in febrile infection related epilepsy syndrome: an international cohort","volume":"7","author":"Lai","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.1021\/acs.jmedchem.7b00408","article-title":"4-Methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridine-Based P2X7 receptor antagonists: optimization of pharmacokinetic properties leading to the identification of a clinical candidate","volume":"60","author":"Letavic","year":"2017","journal-title":"J. Med. Chem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1172\/JCI33737","article-title":"Adenosine kinase is a target for the prediction and prevention of epileptogenesis in mice","volume":"118","author":"Li","year":"2008","journal-title":"J. Clin. Invest."},{"key":"B25","doi-asserted-by":"publisher","first-page":"928009","DOI":"10.3389\/fvets.2022.928009","article-title":"Dogs as a natural animal model of epilepsy","volume":"9","author":"Loscher","year":"2022","journal-title":"Front. Vet. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1007\/s40263-016-0384-x","article-title":"Synaptic vesicle glycoprotein 2A ligands in the treatment of epilepsy and beyond","volume":"30","author":"Loscher","year":"2016","journal-title":"CNS Drugs"},{"key":"B27","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nrd4126","article-title":"New avenues for anti-epileptic drug discovery and development","volume":"12","author":"Loscher","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"B28","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1124\/pr.120.019539","article-title":"Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options","volume":"72","author":"Loscher","year":"2020","journal-title":"Pharmacol. Rev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1021\/acschemneuro.2c00561","article-title":"Characterization of the novel P2X7 receptor radioligand [(3)H]JNJ-64413739 in human brain tissue","volume":"14","author":"Mikkelsen","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1523\/JNEUROSCI.5512-08.2009","article-title":"The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore","volume":"29","author":"Monif","year":"2009","journal-title":"J. Neurosci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/epi.17484","article-title":"Increased uptake of the P2X7 receptor radiotracer (18) F-JNJ-64413739 in the brain and peripheral organs according to the severity of status epilepticus in male mice","volume":"64","author":"Morgan","year":"2023","journal-title":"Epilepsia"},{"key":"B32","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.brainres.2008.03.061","article-title":"Unilateral hippocampal CA3-predominant damage and short latency epileptogenesis after intra-amygdala microinjection of kainic acid in mice","volume":"1213","author":"Mouri","year":"2008","journal-title":"Brain Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nn.2535","article-title":"Selective induction of astrocytic gliosis generates deficits in neuronal inhibition","volume":"13","author":"Ortinski","year":"2010","journal-title":"Nat. Neurosci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","article-title":"Microglia states and nomenclature: a field at its crossroads","volume":"110","author":"Paolicelli","year":"2022","journal-title":"Neuron"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1097\/00001756-200410250-00017","article-title":"Lack of ATP-evoked GABA and glutamate release in the hippocampus of P2X7 receptor-\/- mice","volume":"15","author":"Papp","year":"2004","journal-title":"Neuroreport"},{"key":"B36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.brainres.2006.03.040","article-title":"P2X7 receptor immunoreactive profile confined to resting and activated microglia in the epileptic brain","volume":"1089","author":"Rappold","year":"2006","journal-title":"Brain Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41398-023-02557-5","article-title":"Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder","volume":"13","author":"Recourt","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1177\/0269881120914206","article-title":"Characterisation of the pharmacodynamic effects of the P2X7 receptor antagonist JNJ-54175446 using an oral dexamphetamine challenge model in healthy males in a randomised, double-blind, placebo-controlled, multiple ascending dose trial","volume":"34","author":"Recourt","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1523\/JNEUROSCI.1574-14.2015","article-title":"Reactive astrogliosis causes the development of spontaneous seizures","volume":"35","author":"Robel","year":"2015","journal-title":"J. Neurosci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"17514","DOI":"10.1074\/jbc.M109.053082","article-title":"C-terminal calmodulin-binding motif differentially controls human and rat P2X7 receptor current facilitation","volume":"285","author":"Roger","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B41","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nature12808","article-title":"Transcranial amelioration of inflammation and cell death after brain injury","volume":"505","author":"Roth","year":"2014","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1523\/eneuro.0337-20.2021","article-title":"The kainic acid models of temporal lobe epilepsy","volume":"8","author":"Rusina","year":"2021","journal-title":"eNeuro"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1111\/j.1528-1167.2009.02400.x","article-title":"Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy","volume":"51","author":"Russo","year":"2010","journal-title":"Epilepsia"},{"key":"B44","doi-asserted-by":"publisher","first-page":"6307","DOI":"10.1523\/JNEUROSCI.1469-04.2004","article-title":"Reanalysis of P2X7 receptor expression in rodent brain","volume":"24","author":"Sim","year":"2004","journal-title":"J. Neurosci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1111\/j.1528-1167.2012.03541.x","article-title":"Finding a better drug for epilepsy: preclinical screening strategies and experimental trial design","volume":"53","author":"Simonato","year":"2012","journal-title":"Epilepsia"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1111\/bph.16033","article-title":"The P2X7 receptor contributes to seizures and inflammation-driven long-lasting brain hyperexcitability following hypoxia in neonatal mice","volume":"180","author":"Smith","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1046\/j.1471-4159.2002.00920.x","article-title":"Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus","volume":"81","author":"Sperlagh","year":"2002","journal-title":"J. Neurochem."},{"key":"B48","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41582-019-0217-x","article-title":"Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy","volume":"15","author":"Vezzani","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/nrneurol.2010.178","article-title":"The role of inflammation in epilepsy","volume":"7","author":"Vezzani","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/s41582-022-00727-5","article-title":"Astrocytes in the initiation and progression of epilepsy","volume":"18","author":"Vezzani","year":"2022","journal-title":"Nat. Rev. Neurol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/jnen\/nlv003","article-title":"Increased expression and cellular localization of P2X7R in cortical lesions of patients with focal cortical dysplasia","volume":"75","author":"Wei","year":"2016","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/epi.16406","article-title":"A face-to-face comparison of the intra-amygdala and intrahippocampal kainate mouse models of mesial temporal lobe epilepsy and their utility for testing novel therapies","volume":"61","author":"Welzel","year":"2020","journal-title":"Epilepsia"},{"key":"B53","doi-asserted-by":"publisher","first-page":"113954","DOI":"10.1016\/j.expneurol.2021.113954","article-title":"Spontaneous recurrent seizures in an intra-amygdala kainate microinjection model of temporal lobe epilepsy are differentially sensitive to antiseizure drugs","volume":"349","author":"West","year":"2022","journal-title":"Exp. Neurol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"6282","DOI":"10.3390\/ijms22126282","article-title":"Towards a treatment for neuroinflammation in epilepsy: interleukin-1 receptor antagonist, Anakinra, as a potential treatment in intractable epilepsy","volume":"22","author":"Yamanaka","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"57648","DOI":"10.3791\/57648","article-title":"Quantifying microglia morphology from photomicrographs of immunohistochemistry prepared tissue using ImageJ","volume":"136","author":"Young","year":"2018","journal-title":"J. Vis. Exp."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1308478\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:13:49Z","timestamp":1704672829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1308478\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,8]]},"references-count":55,"alternative-id":["10.3389\/fphar.2023.1308478"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1308478","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,8]]},"article-number":"1308478"}}